Profile

Donna Kersey 
 

Lab Manager, Perlman Laboratory



Children's Memorial Research Center
2430 N. Halsted St Room C303A
Chicago, IL 60614
Phone: (773) 755-6544  

Education 
  Year
Degree
B.S.
Institution
University of Kentucky 

Work Experience  
  Period Description Organization
  July 2002 - Present lab manager Children's Memorial Hospital, Department of Pathology, Chicago, IL 
  December 1990 - May 2002 lab manager Chicago Institute for Neurosurgery and Neuroresearch, Chicago, IL and Evanston, IL 
  May 1990 - December 1990 research technologist II  Northwestern University, Department of Pharmacology and The Cancer Center, Chicago, IL 
  March 1989 - May 1990 research assistant Synergen, Department of Pharmaceutics, Boulder, CO 
  September 1988 - March 1989 senior research analyst University of Kentucky, Department of Pathology and The Cancer Center, Lexington, KY 
  October 1986 - September 1988 senior research analyst University of Kentucky, Department of Microbiology and Immunology and The Cancer Center, Lexington, KY 
  November 1981 - December 1984  lecturer and translator Technical University of Wroclaw, Department of Foreign Language, Wroclaw, Poland
  1980 - 1981 research analyst University of Kentucky, Department of Biochemistry and The Sanders-Brown Center on Aging, Lexington, KY
  1977 - 1980 principal laboratory technician   University of Kentucky, Department of Chemistry, Lexington, KY

Lab Affiliations  
  Perlman Lab  

Recent Publications  
  C. Cutcliffe, D. Kersey, C-C Huang, Y. Zeng, D. Walterhouse, E.J. Perlman for the Renal Tumor Committee of the Children's Oncology Group (2005). Clear cell sarcoma of the kidney: Up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clinical Cancer Research: Nov 15; 11(22):7986 - 7994.
( Download Adobe Acrobat PDF )

Q. Yang, S. Liu, Y. Tian, C. Hasan, D. Kersey, H. Salwen, A. Chlenski, E. Perlman and S. Cohn (2004). Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Research : July 1;64:4531-4538.

R.A. Kroes, A. Jastrow, M.G. McLone, H. Yamamoto, P. Colley, D.S. Kersey, V.W. Yong, E. Mkrdichian, L. Cerullo, J. Leestma and J.R. Moskal (2000). The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Letters: Aug11;156 (2):191-198.

A. Rebbaa, H. Yamamoto, T. Saito, E. Meuillet, P. Kim, D.S. Kersey, E.G. Bremer, N. Taniguchi and J. R. Moskal (1997). Gene transfection-mediated overexpression of beta1,4GlcNAc bisecting oligosaccharides in glioma cell line U373 MG inhibits EGF receptor function. Journal of Biological Chemistry : Apr 4; 272 (14):9275-.

H. Yamamoto, T. Saito, Y. Kaneko, D. Kersey, V.W. Yong, E.G. Bremer, E. Mkrdichian, L. Cerullo, J. Leestma and J.R. Moskal (1997). Alpha2,3-sialyltransferase mRNA and alpha2,3-linked glycoprotein sialylation are increased in malignant gliomas . Brain Research : 755:175-179.

Y. Kaneko, H. Yamamoto, D. Kersey, K. Colley, J. Leestma, and J. Moskal (1996). The expression of Galbeta1,4GlcNAc alpha2,6 sialyltransferase and alpha2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathologica : 91:284-292.

A. Rebbaa, J. Hurh, H. Yamamoto, D. Kersey and E. Bremer (1996). Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology 6: 399-406.

H. Yamamoto, Y. Kaneko, D. VanderMeulen, D. Kersey, E. Mkrdichian, L. Cerullo, and J. Moskal (1995). The expression of CMP-NeuAc:Galbeta1,4 GlcNAc alpha2,6 sialyltransferase and glycoproteins bearing alpha2,6-linked sialic acids in human brain tumors. Glycoconjugate Journal : 12:848-856.

M. Turker, K. Duffin, A. Smith, G. Martin, A. Martin, D. DiMartino, and D. Kersey (1991). Multidrug resistance phenotype associated with selection of an aminopterin resistant dog kidney cell line. Pharmacogenetics : 1:149-160.  

Recent Presentations  
 

D. Kersey, C. Hasan, P. Grundy, E. J. Perlman (March, 2003). Genetic expression profiling of clear cell sarcoma of the kidney (CCSK). platform presentation, Society for Pediatric Pathology Annual Meeting. Washington, DC. 




Back to the top of the page